Align Technology (ALGN, Health Care Supplies) Stock Valuation & Fair Value Favorable on our tests
Align Technology (ALGN, Health Care Supplies) trades at a blended P/E of 13.0, about 67% below its historical normal valuation, with a forward growth estimate of 9.8% and a PEG of 1.32. Analysts' one-year estimates have been hit 36% of the time. Priced at its historical normal P/E of 39.7 on the same blended earnings, the 2026-10-02 close of $143.74 corresponds to about $439 a share. This is a valuation reference, not a price target.
- Price $141.03 at the 2026-10-08 close, 3.6% below the 20-day average ($146.29) and 10.5% below the 50-day ($157.61).
- RSI (14) at 35.6.
- 52-week range $125.79 to $197.51: the price is 28.6% below the high and 12.1% above the low.
The Street vs SeerForecast
Wall Street's mean price target for ALGN is $206.36 across 14 analysts, 46.3% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: favorable on our tests. When the two disagree, start your digging there.
Valuation flags
- No notable valuation flags.
Verdict history
tickerseer's rating moved from mixed on our tests (2026-06-03) to favorable on our tests (2026-10-05).
Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.
Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.
Show all 37 weeks
Frequently asked questions
Is Align Technology stock overvalued?
At a blended P/E of 13.0 versus its historical normal P/E of 39.7, Align Technology trades about 67% below its typical valuation, with a PEG of 1.32 on 9.8% forward growth. tickerseer currently rates it favorable on our tests.
What is Align Technology's fair value and PEG?
Align Technology trades at a blended P/E of 13.0 against a historical normal P/E of 39.7, a PEG of 1.32, and a forward growth estimate of 9.8%. Priced at its historical normal P/E of 39.7 on the same blended earnings, the 2026-10-02 close of $143.74 corresponds to about $439 a share. This is a valuation reference, not a price target.
Has tickerseer's rating of Align Technology changed?
tickerseer's rating moved from mixed on our tests (2026-06-03) to favorable on our tests (2026-10-05).
What is the analyst price target for Align Technology?
The mean Wall Street price target for Align Technology is $206.36 across 14 analysts, 46.3% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.
Industry: Health Care Supplies. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.